Brain and Stress Study
Completed · Phase 4 · Has a placebo group
Conditions studied: Stress, Psychological, Motivation
In brief
Motivational deficits such as anhedonia are core to several psychiatric disorders and underlie significant functional impairment. This double-blind, placebo-controlled crossover trial of minocycline, an anti-\[neuro\]inflammatory agent, examines links between chronic stress and responses to a reward-related motivation task. It will evaluate the effects of pharmacologically attenuating neuroinflammation on behavioral responses to a reward-related motivation task in individuals experiencing unemployment. Understanding the effects of neuroinflammation on reward function among individuals experiencing chronic stress represents a critical first step in identifying novel neuroimmune targets for future clinical trials.
Key facts
- Study ID
- NCT06044090
- Run by
- University of North Carolina, Chapel Hill
- People needed
- 10
- Starts
- 2022-09-12
- Expected to finish
- 2023-12-19
- Last updated by the study team
- 2024-12-18
Who can join
Age: 25 and older, up to 60. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 25-60 years old
- Unemployed (working less than 20 hours per week)
- Have been unemployed for at least 6 months
- Seeking employment
- Having trouble finding a job (i.e., actively seeking and applying for jobs but not successful in landing a job)
- Reports greater than 5 points on Job Stress Items
- Regular access to a mobile phone
You may not qualify if…
- Self-reported physical illnesses: diabetes, cardiovascular diseases, high blood pressure, inflammatory bowel diseases, rheumatoid arthritis, asthma, autoimmune disease, Crohn's disease, ulcerative colitis, lupus
- neurological conditions (e.g., Traumatic Brain Injury, stroke)
- pregnant (as measured by urine pregnancy screen) or breastfeeding
- current use of psychotropic medications
- Current regular recreational drug or alcohol use (i.e., 4 or more times per week)
- chronic diseases that significantly impact inflammatory markers (e.g., cancer)
- known allergies or hypersensitivities to tetracycline antibiotics, aspirin or other NSAIDs
- current antibiotic use
- regular use of steroidal or non-steroidal anti-inflammatory medications (i.e., 2 or more times a week)
Where it is running
- Howell Hall — Chapel Hill, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.